Tagged Articles

attorneys 484 articles

Judge extends deadline for filing Xarelto lawsuits


The deadline for filing Xarelto lawsuits alleging bleeding injuries with the popular blood thinner has been extended 90 days for certain plaintiffs groups due to an influx of complaints that have reportedly inundated the clerk’s office, Judge Eldon Fallon ordered. Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer are facing more than 7,000 lawsuits in a multidistrict litigation alleging the companies’ blood thinner Xarelto caused major bleeding events including gastrointestinal bleeds and brain hemorrhages. Four bellwether trials have already been scheduled for 2017. Another 950 lawsuits have been consolidated into a mass tort program in Pennsylvania with the first scheduled ... Read More

35 states file antitrust lawsuit against drug companies alleging unlawful marketing of addiction treatment


Thirty-five states and the District of Columbia are accusing British drugmaker Indivior of unlawfully manipulating the marketplace to maximize profits when it allegedly conspired to keep less expensive, generic versions of the narcotic addiction treatment Suboxone off the market, California’s attorney general announced. The states filed an antitrust lawsuit in the U.S. District Court for the Eastern District of Pennsylvania against Indivior and MonoSol Rx, a New Jersey-based pharmaceutical dissolving-film company. In 2002, Indivior was granted exclusive rights to market Suboxone tablets until 2009. When the patent expired, the attorneys general claim that Indivior worked out a deal with MonoSol ... Read More

J&J thwarted in attempt to postpone talc trial starting this week

talc ovarian cancer

The third state court trial over the alleged ovarian cancer risks of Johnson and Johnson’s talc powder products is scheduled for Monday, Sep. 26 in Missouri. Jury selection should begin this week. The trial was almost postponed when Johnson and Johnson tried to have the trial removed to federal court. In 2014, J&J had attempted to have the same batch of 45 cases removed from state court for the same reasons, claiming that the cases were “fraudulently misjoined in an effort to defeat diversity jurisdiction.” Both in 2014 and last Wednesday, Sept. 21, U.S. District Judge Jean C. Hamilton found that the ... Read More

Health site warns readers of drugs involved in major lawsuits; Nexium makes the list


Health and Fitness Cheatsheet acknowledges that many of its readers may find it necessary to be on prescription medication. With that necessity comes many anxieties over their health and the safety of the medications they are taking. The health site recently featured an article that addresses its readers’ worries that their medication might be causing major lawsuits, and what that might mean for them. “…it can be extremely troubling when you see that your prescribed medication is causing a major lawsuit. You may feel as though you’re putting your own life at risk. With so many prescription drugs out there, ... Read More

Xarelto litigation gaining momentum nationwide


Litigation involving the blood thinner Xarelto is gaining momentum nationwide. There has been an increase in filings to the multidistrict litigation (MDL), and the first trial dates are soon to be scheduled in the mass tort program in Philadelphia. The Xarelto MDL increase comes just weeks after Judge Eldon E. Fallon of the Eastern District of Louisiana issued an order to extend deadlines another 90 days for certain plaintiffs groups to serve Bayer with complaints. The order came about “due to an influx of complaints” that reportedly inundated the clerk’s office. The first bellwether trials in the Xarelto MDL have ... Read More

Whistleblower Suing Duke University Claims Research Fraud Led To Federal Grants


A former Duke University research biologist has filed a whistleblower lawsuit against the university, alleging fraudulent research and doctored data help Duke and affiliated institutions pull in more than $200 million in federal grants. A False Claims Act lawsuit filed by Joseph Thomas was unsealed last week in a federal court. Mr. Thomas began working in Duke’s cell biology department in 2008. In 2012, he moved to the university’s pulmonary division, where he alleges fellow researcher Erin Potts-Kant used fraudulent data in nearly every experiment in which she participated, then including the bad data in published research, prompting scores of papers ... Read More

Johnson and Johnson, Janssen fight $500K Risperdal verdict


Johnson & Johnson’s Janssen Pharmaceuticals is asking a Pennsylvania appellate court to reverse a half-million-dollar verdict over claims that the drug company’s antipsychotic Risperdal caused a Wisconsin man to grow female breasts, arguing that the trial court allowed improper expert opinion, which gave the jury flawed instructions. Janssen argued that the lower court had allowed plaintiff Timothy Strange’s medical causation expert, a plastic surgeon, to offer opinion that Strange’s use of Risperdal led to gynecomastia, a condition in which adolescent boys develop breast tissue. However, the expert did not use a “generally accepted scientific method,” to rule out other causes ... Read More

Judge adds $6.66 million to landmark $70 million Risperdal award


A Pennsylvania state judge tacked on an additional $6.66 million to the landmark $70 million judgment against Johnson & Johnson and its subsidiary Janssen Pharmaceuticals over allegations that the companies’ antipsychotic drug Risperdal caused a Tennessee adolescent boy to grow female breasts. Plaintiffs attorneys asked Philadelphia County Court of Common Pleas Judge Paula A. Patrick to increase the award amount after the verdict was issued, arguing the family was entitled to delay damages from April 16, 2014, which is one year after the complaint was filed, to July 1, 2016, the date when the verdict was handed down. Attorneys for ... Read More

If there is confusion about talc, who’s to blame?


Johnson & Johnson’s attorneys recently asserted that the plaintiffs’ lawyers “have deliberately created confusion about the science of talc at trial.” Jere L. Beasley, principal and founder of Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., whose trial team represented two plaintiffs in recent trials linking talcum powder to ovarian cancer, issued a statement refuting J&J’s claim, and, in fact, saying just the opposite is true. “It is the height of irony that Johnson & Johnson would claim that our trial team are the ones trying to create confusion surrounding the scientific evidence linking use of talcum powder for feminine hygiene to ovarian ... Read More

Cook Medical’s initial attempts at settling IVC Filter litigation Fail

IVC filter

Hundreds of people who have filed legal claims alleging they have been injured by failed inferior vena cava (IVC) filters have been considering Cook Medical’s talks of settlements. However, U.S. Magistrate Judge Tim Baker and attorneys for both the medical device manufacturer and patients were unable to find common ground to reach a settlement. The meeting ended “without further order.” If the negotiations regarding the settlements fail, then the lawsuits filed by the patients claiming injury related to the IVC filters will go to trial. As of Aug. 15, the number of federal lawsuits in the Multi-District Litigation (MDL) against Cook Medical ... Read More